Sg Americas Securities, LLC Novartis Ag Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Novartis Ag stock. As of the latest transaction made, Sg Americas Securities, LLC holds 10,348 shares of NVS stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,348
Previous 21,296 51.41%
Holding current value
$1.03 Million
Previous $2.45 Million 58.88%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
SELL
$96.78 - $117.18 $1.06 Million - $1.28 Million
-10,948 Reduced 51.41%
10,348 $1.01 Million
Q3 2024

Oct 03, 2024
BUY
$106.13 - $120.89 $357,870 - $407,641
3,372 Added 18.81%
21,296 $2.45 Million
Q2 2024

Jul 12, 2024
BUY
$92.57 - $107.37 $260,214 - $301,817
2,811 Added 18.6%
17,924 $1.91 Million
Q1 2024

May 06, 2024
SELL
$95.27 - $108.47 $2.66 Million - $3.03 Million
-27,934 Reduced 64.89%
15,113 $1.46 Million
Q4 2023

Jan 12, 2024
BUY
$92.27 - $101.54 $804,963 - $885,834
8,724 Added 25.42%
43,047 $4.35 Million
Q3 2023

Oct 13, 2023
BUY
$94.73 - $105.13 $1.4 Million - $1.56 Million
14,797 Added 75.78%
34,323 $3.5 Million
Q2 2023

Jul 10, 2023
BUY
$92.52 - $104.91 $391,359 - $443,769
4,230 Added 27.65%
19,526 $1.97 Million
Q1 2023

Apr 28, 2023
BUY
$80.03 - $92.81 $1.22 Million - $1.42 Million
15,296 New
15,296 $1.41 Million
Q3 2022

Oct 31, 2022
SELL
$74.61 - $87.26 $211,967 - $247,905
-2,841 Reduced 59.51%
1,933 $147,000
Q2 2022

Jul 29, 2022
BUY
$80.52 - $93.75 $384,402 - $447,562
4,774 New
4,774 $404,000
Q1 2022

Apr 29, 2022
SELL
$80.11 - $90.62 $959,477 - $1.09 Million
-11,977 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$79.7 - $88.13 $263,169 - $291,005
-3,302 Reduced 21.61%
11,977 $1.05 Million
Q3 2021

Nov 01, 2021
SELL
$81.78 - $95.14 $14,229 - $16,554
-174 Reduced 1.13%
15,279 $1.25 Million
Q2 2021

Aug 12, 2021
BUY
$85.24 - $94.15 $53,786 - $59,408
631 Added 4.26%
15,453 $1.41 Million
Q1 2021

May 13, 2021
SELL
$83.5 - $98.47 $2.18 Million - $2.58 Million
-26,151 Reduced 63.82%
14,822 $1.27 Million
Q4 2020

Feb 04, 2021
BUY
$78.07 - $94.43 $1.59 Million - $1.92 Million
20,365 Added 98.82%
40,973 $3.87 Million
Q3 2020

Nov 09, 2020
SELL
$82.14 - $91.0 $976,891 - $1.08 Million
-11,893 Reduced 36.59%
20,608 $1.79 Million
Q2 2020

Jul 20, 2020
SELL
$80.93 - $91.1 $2.32 Million - $2.61 Million
-28,697 Reduced 46.89%
32,501 $2.84 Million
Q1 2020

Apr 30, 2020
BUY
$70.67 - $99.01 $909,805 - $1.27 Million
12,874 Added 26.64%
61,198 $5.05 Million
Q4 2019

Jan 28, 2020
BUY
$84.35 - $95.37 $1.91 Million - $2.16 Million
22,599 Added 87.85%
48,324 $4.58 Million
Q3 2019

Nov 04, 2019
SELL
$85.54 - $94.26 $5.47 Million - $6.03 Million
-63,940 Reduced 71.31%
25,725 $2.24 Million
Q2 2019

Jul 29, 2019
BUY
$75.4 - $92.8 $5.04 Million - $6.2 Million
66,820 Added 292.49%
89,665 $8.19 Million
Q1 2019

Apr 29, 2019
BUY
$75.32 - $86.15 $264,825 - $302,903
3,516 Added 18.19%
22,845 $2.2 Million
Q4 2018

Feb 01, 2019
BUY
$73.66 - $82.02 $858,875 - $956,353
11,660 Added 152.04%
19,329 $1.66 Million
Q3 2018

Nov 06, 2018
SELL
$66.94 - $77.43 $1.78 Million - $2.06 Million
-26,619 Reduced 77.63%
7,669 $661,000
Q2 2018

Aug 07, 2018
BUY
$64.91 - $73.36 $1.73 Million - $1.95 Million
26,619 Added 347.1%
34,288 $2.59 Million
Q1 2018

May 03, 2018
SELL
$70.39 - $84.15 $3.2 Million - $3.82 Million
-45,435 Reduced 85.56%
7,669 $620,000
Q4 2017

Jan 24, 2018
BUY
$72.33 - $77.64 $248,670 - $266,926
3,438 Added 6.92%
53,104 $4.46 Million
Q3 2017

Nov 07, 2017
BUY
$74.14 - $77.27 $3.68 Million - $3.84 Million
49,666
49,666 $4.26 Million

Others Institutions Holding NVS

# of Institutions
1,431
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $215B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email